Tenet Healthcare (THC) Receivables - Other (2010 - 2026)

Tenet Healthcare has reported Receivables - Other for 14 years, with the latest figure at $300.0 million in Q2 2026.

• Quarterly Receivables - Other rose 57.07% year-over-year to $300.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $300.0 million (up 57.07% YoY) and the FY2025 annual result came in at $224.0 million, up 17.89% from the prior year.
• Receivables - Other rose to $300.0 million in Q2 2026 per THC's latest filing, from $292.0 million in the prior quarter.
• Over five years, Receivables - Other peaked at $315.0 million in Q1 2024 and troughed at $169.0 million in Q1 2022.
• A 5-year average of $227.3 million and a median of $202.0 million in 2023 frame the typical range for Receivables - Other.
• The sharpest annual moves came in 2024 and 2025: Receivables - Other jumped 66.67% in 2024, then tumbled 38.39% in 2025.
• Over 5 years, Receivables - Other stood at $200.0 million in 2022, then advanced by 4.0% to $208.0 million in 2023, then dropped by 8.65% to $190.0 million in 2024, then gained by 17.89% to $224.0 million in 2025, then soared by 33.93% to $300.0 million in 2026.
• According to Business Quant data, Receivables - Other over the past three periods registered $300.0 million, $292.0 million, and $224.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.